Evaluation of Non-opioid Balanced General Anesthesia in Cardiac Surgery With Extracorporeal Circulation: a Randomized, Controlled, Multicenter Superiority Trial
- Conditions
- Opioid-free AnesthesiaCardiac Surgery
- Interventions
- Drug: Balanced general anesthesia without morphineDrug: Standard general anesthesia balanced with morphineOther: Data collectionOther: Assessment of painOther: Recovery quality score
- Registration Number
- NCT04886453
- Lead Sponsor
- Centre Hospitalier Universitaire Dijon
- Brief Summary
Opioid-free anesthesia (OFA) is a general anesthesia based on the use of hypnotics and non-opioid analgesics (lidocaine, ketamine, dexamethasone, esmolol). This technique has been used for the past 10 years, during which randomized and non-randomized studies have demonstrated a number of positive effects on cardiac function:
* better analgesia and decreased postoperative morphine consumption,
* better respiratory function,
* better hemodynamic stability,
* better postoperative cognitive function.
The hypothesis of the present study is that the use of OFA during cardiac surgery is associated with:
* Improved intraoperative hemodynamic stability
* A decrease in the incidence of postoperative complications
* A reduction in intensive care and hospital length of stay
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 321
-
Patient who has provided written and informed consent
-
Adult patient
-
Patient undergoing cardiac surgery which is:
- Scheduled
- With bypass surgery
- Of the following types: aortic valve surgery, mitral valve surgery, tricuspid valve surgery, atrial myxoma, coronary artery bypass surgery, aortic surgery, combined surgery
- Person not affiliated to national health insurance
- Person under legal protection (curatorship, guardianship)
- Person under court order
- Pregnant or breastfeeding woman
- Adult unable to express consent
- Patient already included once in the study
- Patient requiring emergency surgery within 24 hours
- Patients with hypersensitivity to local anesthetics or opiates or to any of the excipients in the products used
- Patients on antidepressants, neuroleptics such as non-selective MAOIs (iproniazid), selective A MAOI (moclobemide), selective B MAOI (selegiline) gabapentin (Neurontin®)
- Patients with an unprotected atrioventricular conduction disorder
- Patients with a prolonged QTc (> 450 ms) on preoperative ECG
- Patient with severe liver failure (PT< 30%)
- Patient suffering from respiratory failure (Long-term oxygen therapy patient except OSA)
- Patient with uncontrolled epilepsy
- Patient with preoperative cognitive dysfunction (MMS <24)
- Patient with intracranial hypertension
- Patient with chronic kidney failure (dialysis, creatinine > 200 μmol L-1)
- Patient with porphyria
- Patients treated with linezolid (Zyvoxid®)
- Patients with severe arterial hypotension (systolic BP<90 mmHg)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Balanced general anesthesia without morphine - Intervention Data collection - Intervention Assessment of pain - Intervention Recovery quality score - Controle Standard general anesthesia balanced with morphine - Controle Data collection - Controle Assessment of pain - Controle Recovery quality score -
- Primary Outcome Measures
Name Time Method Occurrence of at least one postoperative complication 30 days post-surgery Post-operative complications:
* postoperative neurological dysfunction
* acute renal failure
* acute respiratory failure
* cardiovascular complications
* death
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Chu Dijon Bourgogne
🇫🇷Dijon, France